Skip to content

Establishment of a Clinical Prediction Model and Screening System for Gastrointestinal Cancers in High-Risk Populations Based on Serum Molecular Biomarkers

Establishment of a Clinical Prediction Model and Screening System for Gastrointestinal Cancers in High-Risk Populations Based on Serum Molecular Biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129478
Enrollment
Unknown
Registered
2026-08-05
Start date
2026-08-15
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Tumors

Interventions

Gold Standard:Gastrointestinal endoscopy combined with histopathological diagnosis results were used as the reference standard. Gastrointestinal cancer, adenomas, and polyps were all definitively diag
Index test:An enzyme-linked immunosorbent assay (ELISA) was used to measure the protein concentrations of candidate gastrointestinal tumor biomarkers in the subjects’ serum, and a combined diagnostic

Sponsors

Affiliated Qingyuan Hospital, Guangzhou Medical University,Qingyuan People's Hospital;
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Individuals aged 18–75 who undergo gastrointestinal endoscopy; 2.Individuals diagnosed with adenomas, polyps, or gastrointestinal cancer, or those with no apparent gastrointestinal lesions; 3.A General Informed Consent Form has been signed;

Exclusion criteria

Exclusion criteria: 1.Patients with severe abdominal diseases affecting the heart, lungs, liver, kidneys, pancreas, and other organs; 2.Metastasis of Gastrointestinal Cancer; 3.Include other tumors;

Design outcomes

Primary

MeasureTime frame
Diagnostic Performance of Serum Molecular Biomarkers and Combined Predictive Models for Gastrointestinal Cancers;

Countries

China

Contacts

Public ContactTieli Peng

Affiliated Qingyuan Hospital, Guangzhou Medical University,Qingyuan People's Hospital;

pengtl@163.com+86 763 3113722

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026